State Street’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Hold |
10,710
| – | – | ﹤0.01% | 4168 |
|
|
2025
Q1 | $86K | Sell |
10,710
-5
| -0% | -$40 | ﹤0.01% | 4000 |
|
|
2024
Q4 | $104K | Buy |
10,715
+1,044
| +11% | +$10.1K | ﹤0.01% | 3980 |
|
|
2024
Q3 | $180K | Hold |
9,671
| – | – | ﹤0.01% | 3844 |
|
|
2024
Q2 | $161K | Sell |
9,671
-41,558
| -81% | -$691K | ﹤0.01% | 3876 |
|
|
2024
Q1 | $889K | Buy |
51,229
+4,224
| +9% | +$73.3K | ﹤0.01% | 3500 |
|
|
2023
Q4 | $735K | Sell |
47,005
-473
| -1% | -$7.4K | ﹤0.01% | 3549 |
|
|
2023
Q3 | $2.35M | Buy |
47,478
+6,871
| +17% | +$340K | ﹤0.01% | 3262 |
|
|
2023
Q2 | $3.18M | Buy |
40,607
+2,102
| +5% | +$164K | ﹤0.01% | 3207 |
|
|
2023
Q1 | $3.49M | Buy |
38,505
+248
| +0.6% | +$22.5K | ﹤0.01% | 3125 |
|
|
2022
Q4 | $4.51M | Buy |
38,257
+105
| +0.3% | +$12.4K | ﹤0.01% | 3077 |
|
|
2022
Q3 | $6.92M | Buy |
38,152
+6,839
| +22% | +$1.24M | ﹤0.01% | 2896 |
|
|
2022
Q2 | $2.81M | Buy |
31,313
+6,305
| +25% | +$566K | ﹤0.01% | 3365 |
|
|
2022
Q1 | $3.88M | Sell |
25,008
-28,170
| -53% | -$4.37M | ﹤0.01% | 3303 |
|
|
2021
Q4 | $15.8M | Buy |
53,178
+316
| +0.6% | +$94K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $30.5M | Sell |
52,862
-21,554
| -29% | -$12.4M | ﹤0.01% | 2169 |
|
|
2021
Q2 | $33.8M | Buy |
74,416
+6,401
| +9% | +$2.91M | ﹤0.01% | 2132 |
|
|
2021
Q1 | $36.6M | Buy |
68,015
+35,202
| +107% | +$18.9M | ﹤0.01% | 1968 |
|
|
2020
Q4 | $29M | Buy |
32,813
+21,941
| +202% | +$19.4M | ﹤0.01% | 2006 |
|
|
2020
Q3 | $6.88M | Buy |
+10,872
| New | +$6.88M | ﹤0.01% | 2643 |
|